Page last updated: 2024-09-05

dabigatran and Short Bowel Syndrome

dabigatran has been researched along with Short Bowel Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolbrinker, J; Douros, A; Ebinger, M; Kreutz, R; Schlemm, L	1

Other Studies

1 other study(ies) available for dabigatran and Short Bowel Syndrome

Article	Year
Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome. Thrombosis and haemostasis, 2014, Volume: 112, Issue:2 Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome	2014

Article

Year

Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.

Thrombosis and haemostasis, 2014, Volume: 112, Issue:2

Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Drug Substitution; Factor Xa Inhibitors; Female; Humans; Infarction, Middle Cerebral Artery; Intestinal Absorption; Morpholines; Predictive Value of Tests; Pyridines; Risk Factors; Rivaroxaban; Short Bowel Syndrome; Thiophenes; Treatment Outcome

2014